One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the weight loss drug Wegovy) were about 40 to 70 percent less likely to be ...
Vice-chancellor of London's prestigious King's College, Prof. Shitij Kapur busts myths around longevity hacks and advocates ...
Peter joined Alzheimer’s Research UK in 2014 and has overseen the significant growth of our work with individual philanthropists, trusts and foundations. He leads on our fundraising for our strategic ...
All the experts say socializing, ideally while doing that intellectual activity, can help a lot, because it not only stimulates the brain, but keeps us from feeling lonely. Loneliness often leads to ...
His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...
SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...
Antimicrobials, vaccines, and anti-inflammatories associated with reduced risk for Alzheimer disease and dementia.
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback